Cancer Immunology & Immunotherapy 2008: From Discovery to Development to Drug

Key Points

• Cancer immunology has evolved to identify novel biomarkers for targeted therapies, enhancing immune response against tumors.
• The review demonstrates how innovations in immunotherapy are transforming outcomes for patients with various cancer types.
• Biomarkers play a crucial role in predicting response to therapies, guiding personalized treatment approaches.
• The implications of this work could lead to more effective cancer treatments and improve patient survival rates.